According to foreign media Appleinsider, the documents submitted by British startup Rockley Photonics to the US Securities and Exchange Commission (SEC) show that the company has an important relationship with Apple, and its blood sugar monitoring technology is expected to introduce the new Apple Watch in 2022.
Rockley Photonics is a British start-up company that designs sensors that monitor human blood by infrared rays. It is said that these sensors can monitor heart rate, blood oxygen and even blood sugar and alcohol levels.
According to SEC documents, Rockley Photonics is going to be listed in new york, and the details of its financial relationship are disclosed. According to the document, Apple is considered as one of its "few big customers".
Rockley Photonics claims that its two largest customers account for 99.6% of the company's 2020 revenue 100% and 20 19 revenue, respectively. Although it is not clear whether Apple is the company's largest or second largest customer, it seems that Apple is likely to be very interested in its sensors and its improved products.
Foreign media reported that the company signed a "supply and development agreement" with Apple, and its main income in the future will continue to depend on Apple and another big customer.
Andrew Rickman, CEO of Rockley Photonics, said he expected the technology developed by the company to be applied to consumer products in 2022, but declined to say whether it was related to Apple.
For a long time, there have been rumors that Apple is studying ways to add blood sugar monitoring to Apple Watch. Rumors about "Apple Watch Series 7" say that this function is under development, and Apple has applied for a patent to measure blood sugar without taking blood. If the technology of Rockley Photonics is successfully developed, we can really see the blood sugar monitoring function on Apple Watch Series 7.